CD177 and hepatocellular carcinoma: Previous reports have shown that USP33 promotes metastasis in hepatocellular carcinoma by deubiquitinating transcription factor (SP1) and upregulating cell-surface receptor c-mesenchymal–epithelial transition factor (c-MET) expression [39].